We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+24.97%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$111B
AUM Growth
+$14.9B
Cap. Flow
-$1.95B
Cap. Flow %
-1.76%
Top 10 Hldgs %
40.37%
Holding
493
New
5
Increased
168
Reduced
169
Closed
39

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$710M
2
IOT icon
Samsara
IOT
+$298M
3
MRNA icon
Moderna
MRNA
+$277M
4
SEDG icon
SolarEdge
SEDG
+$272M
5
POOL icon
Pool Corp
POOL
+$234M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.82%
2 Healthcare 22.38%
3 Technology 21.54%
4 Communication Services 11.88%
5 Financials 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFN
326
DELISTED
Infinera Corporation Common Stock
INFN
$24.8K ﹤0.01%
3,200
+259
+9% +$1.88K
DGX icon
327
Quest Diagnostics
DGX
$26.3B
$24.2K ﹤0.01%
171
+26
+18% +$3.72K
AVY icon
328
Avery Dennison
AVY
$13.4B
$23.6K ﹤0.01%
132
+11
+9% +$2K
ROL icon
329
Rollins
ROL
$18.2B
$23.4K ﹤0.01%
623
+61
+11% +$2.2K
KN icon
330
Knowles
KN
$3.34B
$22.6K ﹤0.01%
1,332
+132
+11% +$2.3K
AYX
331
DELISTED
Alteryx Inc
AYX
$22.5K ﹤0.01%
383
+47
+14% +$2.74K
DBX icon
332
Dropbox
DBX
$8.12B
$21.8K ﹤0.01%
1,009
+128
+15% +$2.81K
APLS
333
DELISTED
Apellis Pharmaceuticals
APLS
$21.4K ﹤0.01%
325
+42
+15% +$2.42K
SNA icon
334
Snap-on
SNA
$21.5B
$21.2K ﹤0.01%
86
KFRC icon
335
Kforce
KFRC
$1.06B
$21.2K ﹤0.01%
335
+40
+14% +$2.38K
INMD icon
336
InMode
INMD
$880M
$21.1K ﹤0.01%
659
+63
+11% +$2.16K
MAR icon
337
Marriott International
MAR
$92.3B
$20.4K ﹤0.01%
123
+23
+23% +$3.83K
WMT icon
338
Walmart Inc
WMT
$890B
$20.2K ﹤0.01%
411
+33
+9% +$1.57K
AOS icon
339
A.O. Smith
AOS
$8.7B
$20K ﹤0.01%
289
+26
+10% +$1.69K
BC icon
340
Brunswick
BC
$5.28B
$19.9K ﹤0.01%
243
+24
+11% +$1.99K
CHD icon
341
Church & Dwight Co
CHD
$24.5B
$19.9K ﹤0.01%
225
+26
+13% +$2.17K
PD icon
342
PagerDuty
PD
$902M
$19.8K ﹤0.01%
565
COHR icon
343
Coherent
COHR
$74.2B
$19.6K ﹤0.01%
516
+39
+8% +$1.59K
EXPE icon
344
Expedia Group
EXPE
$37.3B
$19.3K ﹤0.01%
199
+23
+13% +$2.41K
PFE icon
345
Pfizer
PFE
$153B
$19K ﹤0.01%
466
PTRA
346
DELISTED
Proterra Inc. Common Stock
PTRA
$18.9K ﹤0.01%
12,406
GT icon
347
Goodyear
GT
$1.85B
$18.8K ﹤0.01%
1,706
+181
+12% +$2.01K
NTNX icon
348
Nutanix
NTNX
$16.9B
$18.8K ﹤0.01%
723
+86
+14% +$2.33K
TGT icon
349
Target
TGT
$68B
$18.6K ﹤0.01%
112
+15
+15% +$2.47K
LECO icon
350
Lincoln Electric
LECO
$15.4B
$17.4K ﹤0.01%
103
+12
+13% +$1.98K

Similar funds

Baillie Gifford & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Baillie Gifford & Co held 493 positions worth $111B, up 15% from $96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q1 2023 filing shows 5 new, 168 increased, 169 reduced and 39 closed positions. Its largest new stake was Samsara: 18,813,062 shares worth $371M. The largest sale was Salesforce, an estimated $439M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q1 2023 buy was Samsara: 18,813,062 shares worth $371M.
  • Baillie Gifford & Co added most to Advanced Micro Devices in Q1 2023, an estimated $710M increase.
  • Baillie Gifford & Co's biggest Q1 2023 reduction was Illumina, cutting an estimated $351M.
  • Baillie Gifford & Co fully exited Salesforce in Q1 2023, selling an estimated $439M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $111B portfolio in Q1 2023.
  • Baillie Gifford & Co opened 5 new positions and closed 39 in Q1 2023.
  • Baillie Gifford & Co's portfolio value rose 15% quarter-over-quarter to $111B.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.